Emtricitabine
Emtricitabine is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretroviral agents.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of hepatitis B in HIV-HBV co-infected patients
- Post-exposure prophylaxis (PEP) in combination with other agents
- Pre-exposure prophylaxis (PrEP) with tenofovir disoprixil fumarate
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretroviral agents.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of hepatitis B in HIV-HBV co-infected patients
- Post-exposure prophylaxis (PEP) in combination with other agents
- Pre-exposure prophylaxis (PrEP) with tenofovir disoprixil fumarate
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved